Showing results (161-170 of 296) with videos related to
Sort By:
Pageof 30
Magnetic Resonance in Medicine|July 31, 2008
Spatial distribution of RF-induced E-fields and implant heating in MRIPeter Nordbeck, Florian Fidler, Ingo Weiss, et al.The American Journal of Cardiology|July 20, 2024
Risk Factors of Ischemic Stroke in Patients With Atrial Fibrillation After Transcatheter Aortic Valve Implantation from the Randomized ENVISAGE-TAVI AF TrialChristian Hengstenberg, Martin Unverdorben, Helge Möllmann, et al.Blood|April 19, 2015
A phase 1 study of the bispecific anti-CD30/CD16A antibody construct AFM13 in patients with relapsed or refractory Hodgkin lymphomaAchim Rothe, Stephanie Sasse, Max S Topp, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 11, 2018
Outcome of Patients With Early-Stage Infradiaphragmatic Hodgkin Lymphoma: A Comprehensive Analysis From the German Hodgkin Study GroupStephanie Sasse, Helen Goergen, Annette Plütschow, et al.American Journal of Physiology. Heart and Circulatory Physiology|January 18, 2006
Multimodal functional cardiac MRI in creatine kinase-deficient mice reveals subtle abnormalities in myocardial perfusion and mechanicsMatthias Nahrendorf, Jörg U Streif, Karl-Heinz Hiller, et al.International Journal of Molecular Sciences|May 28, 2022
CARS Imaging Advances Early Diagnosis of Cardiac Manifestation of Fabry DiseaseElen Tolstik, Nairveen Ali, Shuxia Guo, et al.Blood Advances|October 25, 2019
Molecular response with blinatumomab in relapsed/refractory B-cell precursor acute lymphoblastic leukemiaNicola Gökbuget, Hagop M Kantarjian, Monika Brüggemann, et al.Blood|May 18, 2012
Immunopharmacologic response of patients with B-lineage acute lymphoblastic leukemia to continuous infusion of T cell-engaging CD19/CD3-bispecific BiTE antibody blinatumomabMatthias Klinger, Christian Brandl, Gerhard Zugmaier, et al.American Journal of Hematology|November 28, 2017
Outcome of patients with relapsed/refractory acute lymphoblastic leukemia after blinatumomab failure: No change in the level of CD19 expressionElias Jabbour, Johannes Düll, Musa Yilmaz, et al.Nuklearmedizin. Nuclear Medicine|January 8, 2024
CXCR4-targeted Theranostics in Hematooncology: Opportunities and ChallengesRudolf Werner, Alexander Haug, Christian Buske, et al.Pageof 30